Apolipoprotein ε4 polymorphism does not modify the association between body mass index and high-density lipoprotein cholesterol: A cross-sectional cohort study

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Rahilly Tierney, Catherine R ^a,c,d   Arnett, Donna K ^e   North, Kari E ^f   Pankow, James S ^g   Hunt, Steven C ^h   Ellison, R Curtis ⁱ   Gaziano, J Michael ^a,b,c,d   Djoussé, Luc ^a,b,c,d  

^a Massachusetts Veterans Epidemiology Research and Information Center   (United States)

^b Geriatric Res Educ Clin Ctr   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f IL   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h UNIVERSITY OF UTAH   (United States)

ⁱ BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adiposity; apolipoproteins; body mass index; genetic epidemiology; HDL cholesterol; lipid metabolism

Indexed keywords

APOLIPOPROTEIN E4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BODY MASS; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EXERCISE; FAT INTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN POLYMORPHISM; RANDOMIZED CONTROLLED TRIAL; SMOKING; AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; BLOOD; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; MIDDLE AGED; MULTICENTER STUDY; UNITED STATES;

ADULT; AGED; ALLELES; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; APOLIPOPROTEIN E4; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; OVERWEIGHT; POLYMORPHISM, GENETIC; UNITED STATES;

EID: 80053173556     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-167     Document Type: Article

References (21)

1. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR, Am J Med 1977 62 707 714 10.1016/0002-9343(77)90874-9 193398 (Pubitemid 8110784)
2. HDL cholesterol and cardiovascular disease. Four prospective American studies. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR, Bandiwala S, Tyroler HA, Circulation 1989 79 8 15 10.1161/01.CIR.79.1.8 2642759 (Pubitemid 19043669)
3. The Tromsø heart-study: HDL and coronary heart-disease: a prospective case-control study. Miller NE, Thelle DS, Forde OH, Mjos OD, Lancet 1977 1 965 968 67464
4. Association of high-density-lipoprotein cholesterol with mortality and other risk factors for major chronic noncommunicable disease in samples of US and Russian men. Perova NV, Organov RG, Williams DH, Irving SH, Abernathy JR, Deev AD, Shestov DB, Zhukovsky GS, Davis CE, Tyroler HA, Ann Epidemiol 1995 5 179 185 10.1016/1047-2797(94)00104-2 7606306
5. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Jacobs DR, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA, Am J Epidemiol 1990 131 32 47 2293751 (Pubitemid 20014697)
6. HDL cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial. Gordon DJ, Knoke J, Probstfield JL, Superko R, Tyroler HA, Circulation 1986 74 1217 1225 10.1161/01.CIR.74.6.1217 3536151 (Pubitemid 17189240)
7. HDL cholesterol and coronary, cardiovascular, and all cause mortality among middle-aged Norwegian men and women. Svensvold I, Urdal P, Thürmer H, Tverdal A, Lund-Larsen PG, Foss OP, Eur Heart J 1992 13 1155 1163 1396823
8. High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study. Enger SC, Hjermann I, Foss OP, Helgeland A, Holme I, Leren P, Norum KR, Artery 1979 5 170 181 231954 (Pubitemid 9135915)
9. Apolipoprotein E: far more than a lipid transport protein. Mahley RW, Rall SC Jr, Annu Rev Genomics Hum Genet 2000 1 506 537
10. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ, JAMA 1994 272 1666 1671 10.1001/jama.272.21.1666 7966894 (Pubitemid 24359137)
11. Plasma lipoproteins and lipase and lecithin: cholesterol acyltransferase activities in obese subjects before and after weight reduction. Weisweiler P, J Clin Endocrinol Metab 1987 65 969 973 10.1210/jcem-65-5-969 3667889 (Pubitemid 17162647)
12. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Dattilo AM, Kris-Etherton PM, Am J Clin Nutr 1992 56 320 328 1386186
13. Eight-year change in body mass index and subsequent risk of cardiovascular disease among healthy non-smoking men. Bowman TS, Kurth T, Sesso HD, Manson JE, Gaziano JM, Prev Med 2007 45 436 441 10.1016/j.ypmed.2007.06.022 17727941 (Pubitemid 350193305)
14. Impact of age and body size on inter-individual variation in measures of lipid metabolism: influence of gender and apolipoprotein E genotype. Lussier-Cacan S, Bolduc A, Xhignesse M, Niynsenga T, Connelly PW, Sing CF, Clin Genet 2000 57 35 47 10733234 (Pubitemid 30105559)
15. Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: the Bogalusa Heart Study. Srinivasan SR, Ehnholm C, Elkasabany A, Berenson GS, Metabolism 2001 50 696 702 10.1053/meta.2001.23299 11398147 (Pubitemid 32551824)
16. Do polymorphisms of apoB, LPL or apoE affect the hypocholesterolemic response to weight loss? Kee F, Young IS, Poirier O, McMaster D, McCrum E, McGeough J, Patterson CC, Dallongeville J, Cambien F, Evans AE, Atherosclerosis 2000 153 119 128 10.1016/S0021-9150(00)00378-6 11058706
17. NHLBI Family Heart Study: objectives and design. Higgins M, Province M, Heiss G, Eckfeldt J, Ellison RC, Folsom AR, Rao DC, Sprafka JM, Williams R, Am J Epidemiol 1996 143 1219 1228 8651220 (Pubitemid 26178734)
18. Apolipoproten E (APOE) allele distribution in the world. Is APOE*4 a "thrifty" allele? Corbo RM, Scacchi R, Ann Hum Genet 1999 63 301 310 10.1046/j.1469-1809.1999.6340301.x 10738542
19. Apolipoprotein E genotyping on agarose gels. Reymer PW, Groenemeyer BE, van de Burg R, Kastelein JJ, Clin Chem 1995 41 1046 1047 7600689
20. Reproducibility and validity of a semiquantitative food frequency questionnaire. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE, Am J Epidemiol 1985 122 51 65 4014201 (Pubitemid 15010435)
21. Triglycerides and coronary heart disease revisited (again). Criqui MH, Ann Intern Med 2007 147 425 427 17876026 (Pubitemid 351664544)